The best peptides for anxiety, ranked by evidence, are not very well supported at all. No peptide is approved for anxiety in the US. Selank, a nasal peptide sold in Russia, has the most human data, but it rests on a few small Russian studies of around 60 patients each without strong placebo controls.[4][5] DSIP has no anxiety trials,[9] and oxytocin did not improve overall outcomes when added to exposure therapy for social anxiety.[13] The best-supported treatments are cognitive behavioral therapy and SSRI or SNRI medicines.[1]
This guide grades each option. For related compounds, see our nootropic peptides hub.
Evidence at a glance
| Peptide or treatment | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| CBT; SSRIs and SNRIs | FDA-approved for this use (medicines) | First-line in international guidelines[1] | Approved (not peptides) | n/a |
| Selank | Small human studies | Anxiety relief similar to benzodiazepines in ~60-patient Russian studies[4][5] | Not approved | Selank |
| Oxytocin (nasal) | Small human studies | No overall benefit added to exposure therapy[13] | Approved only as an injection for labor and postpartum bleeding | Oxytocin |
| DSIP | No evidence for anxiety (weak insomnia data) | Insomnia trials gave weak results[10] | Not approved | DSIP |
| Semax | Animal or lab only (for anxiety) | Brain connectivity changes in healthy volunteers[8] | Not approved | Semax |
“Best” here means best-supported by evidence, not proven to work.
Start with what works
The World Federation of Societies of Biological Psychiatry reviewed 1,007 randomized trials for its 2023 guideline. It lists SSRIs and SNRIs as first-line medicines and cognitive behavioral therapy (CBT) as the first-line psychotherapy for panic disorder, generalized anxiety, social anxiety and related conditions.[1] The National Institute of Mental Health also describes therapy, medicine or both as standard treatment.[2]
Selank: the most data, still thin
Selank is a 7-amino-acid peptide based on tuftsin, a fragment of an immune protein. It is sold in Russia as nasal drops for anxiety.[3]
What the human studies found:
- Selank vs medazepam (2008): 62 patients with generalized anxiety or neurasthenia got Selank or the benzodiazepine medazepam. Anxiety relief was similar, and Selank also seemed to reduce fatigue.[4]
- Selank vs phenazepam (2014): in 60 patients with anxiety and somatoform disorders, the authors reported clear anxiety relief lasting a week after the last dose.[5]
- Selank added to phenazepam (2015): in 70 patients, adding Selank appeared to speed the response and reduce the benzodiazepine’s side effects, such as sedation and memory problems.[6]
These studies were small, published in Russian journals, and compared Selank with other drugs rather than with placebo. A 2021 US review described Selank as a poorly studied Russian drug with a GABA-related mechanism that is sold to US consumers as a supplement.[7]
Oxytocin: calmer brain scans, no clear treatment benefit
Oxytocin is a hormone linked to bonding and stress. In a brain-imaging study of 18 people with social anxiety, a single nasal dose calmed the amygdala’s overreaction to fearful faces.[14] But in a randomized trial of 25 people with social anxiety disorder, adding oxytocin to exposure therapy improved how people rated their own appearance and speech, without improving overall symptoms compared with placebo.[13]
DSIP: a sleep peptide without anxiety trials
DSIP, or delta sleep-inducing peptide, is marketed for sleep and stress. Scientists have never identified a gene or receptor for it.[11] In a double-blind study of 16 people with chronic insomnia, effects were weak, and the authors concluded it was unlikely to be of major benefit.[10] FDA staff reviewed DSIP in 2026 for insomnia and other uses and recommended against allowing it in compounding,[9] and advisers reportedly voted 6 to 7 against it.[12] We found no controlled anxiety trials. See DSIP vs melatonin.
Semax: not an anxiety peptide
Semax is often sold alongside Selank. In healthy volunteers, both changed brain connectivity on scans in different ways,[8] but Semax is studied mainly for stroke and cognition, not anxiety. Compare them in Selank vs Semax.
How to read Selank claims online
Selank is often marketed as a “non-addictive benzodiazepine alternative.” That claim goes further than the data. The Russian studies compared Selank with benzodiazepines over a few weeks, did not use a placebo group and did not formally study dependence or withdrawal.[4][5] The US review that flagged Selank as poorly studied grouped it with other GABA-acting products sold as supplements, including phenibut, which has been linked to a rise in poison control calls.[7]
Small studies against another active drug can be useful early signals, but they are not enough to show a medicine works or is safe for long-term use. If benzodiazepine side effects or dependence are a concern, ask your prescriber about a supervised taper and a first-line option such as an SSRI or SNRI, together with CBT.[1]
Safety and legal status
- Not FDA-approved: none of these peptides is approved for anxiety in the US, and FDA lists several research peptides among compounding substances with safety concerns.[16]
- Unknown products: European drug-control labs have found Selank and Semax in seized products and noted they are sold online without completed clinical trials.[15]
- Dependence and interactions: Selank’s long-term safety, dependence risk and interactions with antidepressants or benzodiazepines are not well studied.[7]
Questions to ask your clinician
- Would CBT or another structured therapy fit my type of anxiety?
- Is my medicine at the right dose, and what are the alternatives?
- Could any supplement or peptide interact with my current treatment?
- How long should I give a new treatment before judging whether it works?
- If my anxiety is mostly about sleep, what are the proven sleep treatments?
For related reading, see peptides for depression, peptides for PTSD and Dihexa vs Semax vs Selank.
